Top Digestive and Metabolic Diseases conferences 2019 | Digestive Diseases Conferences Italy | Digestive Disorders Conferences Italy | Meetings Italy Europe Asia USA Middle East

Theme: TBD

Digestive and Metabolic Diseases 2020

Digestive and Metabolic Diseases 2020

Digestive Disease 2020 Conference is delighted to welcome the participants from all over the world to attend the prestigious International Conference on Digestive Disease scheduled at TBD . Digestive Disease 2020 is the best platform with its well organized scientific program to the audience which includes symposiums, workshops, keynote lectures, plenary talks, panel discussions and poster sessions on latest research and technological developments in the arena as well as therapeutic aspects.

The gathering gives the worldwide arena to global researchers, professors, doctors, scientists gastroenterologists, hepatologists , diabetologists, endoscopists , internists, physicians, microbiologists, virologists, pathologists, oncologists, surgeons and toxicologists, students, business delegates and young researchers across the globe to voice their examination discoveries to the world to learn about current and upcoming issues, explore new developments in the field of gastroenterology and interact with others with similar interest.

Conference Name	Place	Date
Digestive Diseases Conferences	Europe	TBD

Track 1: Advancements in Digestive Disease Treatment

Progression in the analysis and treatment of gastrointestinal diseases has been outstanding in the running years. Examination is going on new diagnostic strategies and novel therapeutic frameworks for gastresophageal reflux sickness (GERD), pancreatic-biliary and post-surgical issues, Barrett's throat, neuroendocrine tumours and gastrointestinal stromal tumours. In Japan, gastric development is the second driving purpose behind threat passing.

Relevant conferences: 16^th world congress on gastroenterology & therapeutics (world gastroenterology 2019 ) | January 30-31, 2019 in Bangkok, Thailand | world congress on pancreatic cancer and liver diseases| January 30-31, 2019 |25th international conference on human metabolic health- diabetes, obesity & metabolism"| march 21-22,2019dubaiuae kyo, japan.|15^th annual congress on gastroenterology & Hepatology |September 27-28, 2019 in Hong Kong |7^th world congress on hepatitis & liver diseases | may 15-16,2019 |7^th international conference on Hepatology (Hepatology 2019) | Sydney, Australia July 15-16, 2019|21^st world congress on advances in gastroenterology and Hepatology | may 15-16,2019 at Melbourne, Australia |14^th euro-global gastroenterology conference (gastro congress 2018)| to be held in Zurich, Switzerland during July 08-09, 2019 | 19th international conference on gastroenterology and Hepatology| Abu Dhabi, uae November 11-12, 2019 |13^thInternational Conference on Endocrinology, Diabetes and Metabolism| during April 08-09, 2019 at Wellington, New Zealand |21^stAsia Pacific Diabetes Conference |Osaka, Japan April 17-18, 2019.

Track 2: Gastrointestinal Oncology

Gastrointestinal disease alludes to dangerous states of the gastrointestinal tract (GI tract) and embellishment organs of processing, including the throat, stomach, biliary framework, pancreas, small digestive system, internal organ, rectum and anus. The symptoms are associated to the damaged organ and can include obstruction (leading to difficulty swallowing or defecating), abnormal bleeding or other related problems. The finding regularly requires endoscopy, trailed by biopsy of suspicious tissue. The treatment relies upon the area of the tumour, and additionally the kind of disease cell and whether it has attacked different tissues or spread somewhere else. These components likewise decide the guess.

Track 3: Liver diseases & Transplantation

Liver is the largest organ inside your body. It helps your body digest food, store energy, and remove poisons. Indications of liver sickness can differ, however they frequently incorporate swelling of the abdomen and legs, bruising easily, changes in the shade of your stool and urine. The first attempted human liver transplant was performed in 1963 by Dr. Thomas Starzl, although the paediatric patient died intra operatively due to uncontrolled bleeding. In spite of the improvement of suitable surgical procedures, liver transplantation stayed trial through the 1970s, with one year tolerant survival in the region of 25%. Liver transplantation is now performed at over one hundred centers in the US, as well as numerous centres in Europe and elsewhere.

Track 4: Micro biome in Gastrointestinal & Liver

The micro biome comprises all of the genetic material within a micro biota (the entire collection of microorganisms in a specific niche, such as the human gut). This can also be referred to as the metagenome of the micro biota. Liver cirrhosis occurs as a consequence of many chronic liver diseases that are prevalent worldwide. Here we characterize the gut micro biome in liver cirrhosis by comparing 98 patients and 83 healthy control individuals. We manufacture a reference gene set for the accomplice containing 2.69 million genes, 36.1% of which are novel. Quantitative metagenomics reveals 75,245 genes that differ in abundance between the patients and healthy individuals (false discovery rate < 0.0001).

Track 5: Gallstones

They aren't generally stones. They're bits of strong material that shape in the gallbladder, a little organ situated under the liver. You won't not know you have them until the point that they obstruct a bile pipe, causing torment that you have to escape. The two fundamental sorts are: Cholesterol stones, Pigment stones.

Track 6: Inflammatory Bowel Disease

Inflammatory bowel disease (IBD) represents a group of intestinal disorders that cause prolonged inflammation of the digestive tract. The digestive tract comprises the mouth, oesophagus, stomach, small intestine, and large intestine. It’s responsible for breaking down food, extracting the nutrients, and removing any unusable material and waste products. Inflammation anywhere along the digestive tract disrupts this normal process. IBD can be very painful and disruptive, and in some cases, it may even be life-threatening.

Track 7: Haemorrhoids

Haemorrhoids (HEM-uh-roids), also called piles, are swollen veins in your anus and lower rectum, similar to varicose veins. Haemorrhoids have a number of causes, although often the cause is unknown. They may result from straining during bowel movements or from the increased pressure on these veins during pregnancy. Haemorrhoids may be located inside the rectum (internal haemorrhoids), or they may develop under the skin around the anus (external haemorrhoids).

Track 8: Colorectal Disease

Together the colon and rectum make up our large intestine; they each play separate and important roles in our digestive process. For that reason, medical disorders that affect this area of the body may be called “colorectal” or “intestinal” disorders. Colorectal conditions range from common and often treatable problems such as chronic constipation, to rare or life-threatening disorders including anal cancer.

Track 9: Gastrointestinal Disorders, Symptoms & Drug delivery

Gastrointestinal motility is characterized by the movements of the digestive system, and the transit of the contents within it. Gastrointestinal Disorder is the disorder related to gastrointestinal tract namely the oesophagus, stomach, small intestine, large intestine and rectum, and the accessory organs of digestion, the liver, gallbladder, and pancreas. Gastrointestinal disorders include such conditions as constipation, irritable bowel syndrome, haemorrhoids, anal fissures, perianal abscesses, anal fistulas, perianal infections, diverticular diseases, colitis, colon polyps and cancer.

Track 10: Genetics and Molecular Biology in Gastroenterology

Molecular biology has become an integral part of basic and clinical gastroenterology. A broad spectrum of infectious, inherited and malignant gastrointestinal diseases can now be studied by molecular methods, including polymerase chain reaction, hybridization and DNA sequence analyses. At recent progress in the molecular analysis of Whipple's disease and colorectal cancer, two major problems in clinical gastroenterology. Genetics have led to an increased understanding of the genetic determinants of gastrointestinal disorders.

Track 11: Paediatric Gastroenterology

Paediatric gastroenterologists treat children from the new born period through the teen years. Kids are developing and have remarkable therapeutic needs. They can't generally answer therapeutic inquiries and are not generally ready to be patient and helpful. Paediatric gastroenterologists know how to analyse and treat youngsters in a way that makes them casual and agreeable. The aim of the study of paediatric gastroenterology is to reduce infant and child rate of deaths, control the spread of infectious disease, promote healthy lifestyles for a long disease-free life and help ease the problems of children and adolescents.

Track 12: Pancreatic Cancer, Diseases and Treatments

Issues with the pancreas can prompt numerous medical issues like Pancreatitis, when stomach related chemicals begin processing the pancreas itself, pancreatic cancer, Cystic fibrosis it is a hereditary issue in which thick, sticky bodily fluid can likewise square tubes in your pancreas. The pancreas additionally assumes a part in diabetes.

Track 13: Diabetic Ketoacidosis

It is a life threatening problem and needs awareness about its prevention. It occurs when body doesn’t produce enough insulin and body cells can’t use sugar in blood for energy then body start using fat as fuel for energy. When the body continue to burn fat, it makes acids called ketones. If this process remains continue for a period of time, it will build up in body and can change the chemical balance of body and will affect the whole body functions. It is seen more in young ones having type 1diabetes.

Track 14: Acid Related Diseases

This is divided into 7 sections : the production of acid in the stomach, the regulation of gastric acid secretion, the pharmacology of acid secretion, the biology of acid-related diseases, gastric and duodenal ulcer disease, gastro oesophageal reflux disease, and Helicobacter pylori. Each of these sections is extremely well written and provides historical insights into the various areas. For example, the first section point out that Paracelsus was one of the first to relate chemistry to disease; however, he was under the mistaken assumption that acid found in the stomach was ingested.

Section 2 presents an accounting of William Beaumont’s study of the gastric fistula in Alexis Saint Martin, which was the result of a gunshot wound. Also included in this section is the accounting of Pavlov’s delineation of vagal function in relation to the GI tract. Other important milestones of gastric physiology that are recounted include Codes’ study of the relationship of histamine to gastric secretion and the work of Bayless and Starling in identifying the hormone secretin.

In Section 2, gastric acid secretion and its neural and endocrine regulation is covered in a comprehensive manner as are all aspects of parietal cell function.

The history of the therapeutic approach to acid-related diseases is detailed in Section 3 and includes the Sippy diet, antacids, sulphated polysaccharide (sulcralfate), histamine H2 receptor antagonists, and proton pump inhibitors along with surgery.

Section 4 deals with the barrier function of the upper GI tract, intra gastric pH, pepsin, intrinsic factor, and regulation of the growth of gastric epithelium.

The final section deals with Helicobacter pylori and covers its well-known history and the consequences of gastric colonization along, with the pathogenesis and treatment options

Track 15: Gastrointestinal Endoscopy

Gastrointestinal endoscopy is a technique that enables your specialist to take a gander at within covering of your throat your stomach, and the initial segment of your small digestive tract. A thin, adaptable review apparatus called an endoscope (scope) is utilized. The tip of the extension is embedded through your mouth and after that tenderly moved down your throat into the throat, stomach and duodenum (upper gastrointestinal tract). In patients with OGIB, upper and lower GI tract endoscopies regularly are rehashed before little gut assessment because significant starting endoscopic miss rates have been accounted for.

Clinical endoscopy

Demonstrative Endoscopy

Restorative Endoscopy

Colonoscopy and Sigmoidoscopy

Endoscopic Methods

Advances in Endoscopy

Related Societies and Association : International Society of Gastrointestinal Oncology, International Society of Gastrointestinal Oncology, Saudi Gastroenterology Association World Gastroenterology Organisation, Endoscopy Group and Gastroenterology Associates of Pensacola, Indian Society of Gastroenterology: ISG, American Gastroenterological Association , American Society for Gastrointestinal Endoscopy, Idaho Gastroenterology Associates, Saudi Gastroenterology Association, International Society of Gastrointestinal Oncology

Track 16: Neurogastroenterology and Motility
Normal contractions of the gut (called peristalsis) move food down the intestinal tract from the oral cavity to the rectum and facilitate absorption of nutrients. These peristaltic contractions occur when the muscle layers of the gut and the nerves embedded in them work together in a synchronized manner. Motility disorders of the gut can occur in association with abnormalities in other organ systems such as the central nervous system, mitochondrial disorders, muscular dystrophies and others. Neurogastroenterology helps in the comprehension of the elements of the parasympathetic, thoughtful, and enteric divisions of the gastrointestinal tract. Neurons are available on each surface of our body. It is because of these neurons that we feel and can do of the deliberate and automatic activities. So also, neurons are likewise found on the gastrointestinal surfaces. It is because of these neurons that we can swallow the nourishment, and which is then taken to the distinctive organs for their working, which thus is again organized by the cerebrum.

Parasympathetic division
Gastrointestinal Motility
Thoughtful division
Enteric division
Peristaltic reflex

Digestive and Metabolic diseases 2019 Market Analysis

Description:

Metabolism is a process in which human body generates energy from the food humans eat. The food that humans consume comprises proteins, carbohydrates, and fats. Chemicals in human digestive system break the food parts down into sugars and acids. Metabolic disorders occur when abnormal chemical reactions in human body disturb this process. This is due to enzyme deficiency: as all processes in the body are controlled by enzymes. Any disturbance in the pathways involved in the development and metabolism of carbohydrates, proteins, and fats, leads to metabolic disorder.

While in 2015, the market size of metabolic disorder therapeutics was valued over USD XX million. The global metabolic disorder therapeutics market is projected to grow with a CAGR between 4.8% and 5.3% over the forecast period of 2018-2023 and reach USD 200 billion by 2023.

Metabolism is a process in which human body generates energy from the food humans eat. The food that humans consume comprises proteins, carbohydrates, and fats. This is due to enzyme deficiency as all processes in the body are controlled by enzymes. Any disturbance in the pathways involved in the development and metabolism of carbohydrates, proteins, and fats, leads to metabolic disorder.

Increase in academia-industry collaborations for drug developments is the key factor responsible for the growth of metabolic disorder therapeutics market. Furthermore, growing diabetic population is significantly contributing to the growth of this market. Low compliance, adherence rate for metabolic disorder therapies and availability of alternative treatment option are the major challenges faced by the players operating in this market. The global metabolic disorder therapeutics market is anticipated to present several opportunities of growth of market size over the forecast period due to strategic collaborations and acquisition and increased R & D investment.

Market Insights

Segment Covered

The report on global metabolic disorders therapeutics market covers segments such as, disease type and product. On the basis of disease type the global metabolic disorders therapeutics market is categorized into diabetes, obesity, hypercholesterolemia and lysosomal storage disease. On the basis of product the global metabolic disorders therapeutics market is categorized into metachromatic leukodystrophy, globoid leukodystrophy,hepatic encephalopathy and others.

The report segments the metabolic disorder therapeutics market by types of disease and by region. Among segments given above; diabetes market is estimated to be 24.9 billion USD in 2017, it is growing because of the higher growth in the global type 2 diabetic population. The Oral Anti Diabetes Market is expected to witness a growth of about 28% from 2018 to 2023 and it is expected to reach USD 34.1 billion by 2023.The increasing diabetic population across the globe is one of the significant factors propelling the growth of this segment.

Gastroenterology in America:

Over the review period in America, the changing lifestyles of consumers resulted in a significant increase in dietary ailments that are reflected in the positive performance of digestive remedies. According to the market analysis, digestive disorders affect more than 20 million people each year. Inflammatory bowel disease (IBD), heartburn, acid reflux and irritable bowel syndrome (IBS) are among the most common digestive disorders.

Gastroenterology in Asia:

Though the Asia-Pacific market for probiotics is globally the largest, accounting for an estimated share of 38% in 2018, market maturity is expected to curtail growth prospects over the coming years, with other regions taking the lead. Within Asia-Pacific, Japan forms the largest probiotics market, with an estimated share of 45% in 2018. However, growth in demand for probiotics is likely to be the fastest in China, with a forecast CAGR of about 13.2% between 2017 and 2023. By segment, human applications such as dietary supplements, functional foods & beverages and specialty nutrients dominate the probiotics market in the region. expected to grow at a CAGR of 6.6% over the forecast period.

Top Universities across the world:

1. University of Oxford

2. Stanford University

3. University of Cambridge

4. Harvard University

5. Princeton University

6. Imperial College London

7. ETH Zurich – Swiss Federal Institute of Technology Zurich

Associations/Societies across the world:

1. American Gastroenterological Association

2. World Gastroenterology Organisation

3. Ontario Association of Gastroenterology

4. Canadian Association of Gastroenterology

5. United European Gastroenterology

6. Florida Gastroenterological Society

Top universities in London:

1. University College London (UCL)

2. Imperial College London

3. King's College London

4. Queen Mary, University of London

5. Royal Holloway, University of London

6. Birkbeck College, University of London

7. City, University of London

8. Brunel University

Associations/Societies in London:

1. British Society of Gastroenterology (BSG)

2. London Gastrointestinal Associates

3. Association of upper Gastrointestinal Surgeons of Great Britain

4. The Royal Society of Medicine

5. Associations of Medical Research Charities

Geographic Coverage and Analysis:

North America was the largest market for metabolic disorder and likely to continue its dominance with a majority market shares globally over the period of 2017 to 2023. The US was the major contributor in the region, as half of the adult population in the country is suffering from diabetes over past couple of years. Following North America, Asia Pacific accounted to be the most prominent region for metabolic disorder over the forecast period. Healthcare reforms across the region and rising diabetic population especially in India are anticipated to boost the growth in the Asia - Pacific market.

Attribute	Details
Base year for estimation	2017
Review Period	2012-2017
Forecast Period	2018 – 2023
Market Representation	Revenue in USD billion and CAGR from 2018 – 2023
Regions covered	North America, Europe, Asia-Pacific, Middle East and Africa and Latin America
Report coverage	Revenue forecast, market share analysis, and market dynamics

Report highlights

In addition, this report provides insights on the factors that are driving and restraining the global demand of metabolic disorders therapeutics globally as well as regionally.

We also have highlighted future trends in the metabolic disorders therapeutics market that will impact the demand during the forecast period.This report will help manufacturers, suppliers and distributors of the metabolic disorders therapeutics market to understand the present analysis.

The report provides insights into the market using analytical tools such as Porter’s five forces analysis and value chain analysis of metabolic disorders therapeutics market the study highlights current market trends and provides forecast from 2017-2023

We also have highlighted future trends in the metabolic disorders therapeutics market that will impact the demand during the forecast period

This report will help manufacturers, suppliers and distributors of the metabolic disorders therapeutics market to understand the present and future trends in this market and formulate their strategies accordingly.

Top Companies Profile:

The companies covered in the report include:

-Novo Nordisk
-Sanofi
-Merck
-AstraZeneca
-EliLily
-AbbVie
-Actelion Pharmaceuticals
-Amicus Therapeutics
-Arena Pharmaceuticals
-Astellas Pharma
-Biocon
-Biospheres
-Boehringer Ingelheim
-CKDBio
-Concord Biotech
-ConjuChem
-CureDm
-CymaBay Therapeutics
-Daewoong
-Daiichi Sankyo
-Dance Biopharm

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	2019-11-18
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed
Poster Opportunity Closed	Click Here to View

5th International Conference on Digestive and Metabolic Diseases 2019-11-18 Europe 2020

Recommended Global Gastroenterology Conferences

USA & Americas

Europe & Middle East

Asia Pacific

Meet Inspiring Speakers and Experts at our 1000+ Global Events inclusive of 300+ Conferences, 500+ Workshops and 200+ Symposiums Every year on Medical, Pharma, Engineering, Science, Technology and Business.

For more Conferences visit www.conferenceseries.com

Quick Links

Digestive and Metabolic Diseases 2020

Conference Highlights

To Collaborate Scientific Professionals around the World

Useful Links

Special Issues